About
1,736.00DKK+13.50 +0.78%
Closed • Updated at 11:54 GMT+00:00Market Cap$15.96B
P/E Ratio20.31
Volume35.3K
Beta0.55
RSI51.95
Gross Margin93.31%
Genmab A/s — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Major Shareholder Announcement
May 7 2026
Genmab Announces Financial Results for the First Quarter of 2026
Apr 17 2026
Genmab A/S Share Capital Reduction
Apr 14 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
Apr 13 2026
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
Translate